Tag: Europe Pharmacogenetics Testing in Psychiatry Depression Market
Is the Europe Pharmacogenetics Testing in Psychiatry/Depression Market Transforming Mental Healthcare?
The Europe pharmacogenetics testing in psychiatry/depression market was valued at USD 461.10 million in 2025 and is projected to reach USD 912.04 million by 2033, growing at a CAGR of 8.9% from 2026 to 2033.
0
0
0
24 Jun, 05:01 AM
